Skin AgingPhase 4NCT00492479
An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging
A Phase 4 study testing Kinerase Pro+Therapy Line day repair, serum, night repair, Kinerase Pro+Therapy Line Ultra rich day repair and LubriDerm in people with Skin Aging, run by Innovative Medical at 1 site in United States.
Trial summary
The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging. Read more about this study
- Who is it for?
- Ages 35 to 55 years, women only
- Conditions the study is for
- Skin Aging
- What is being tested?
- Kinerase Pro+Therapy Line day repair, serum, night repair, Kinerase Pro+Therapy Line Ultra rich day repair and LubriDerm
- How many people
- Not given
- Where
- 1 siteUnited States
- Study dates
- Jun 2007to Dec 2007
- Phase
- Phase 4
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 35 to 55 years
- Women only
- Adult
Who may be able to join
- Female patients 35-55 years of age with at least moderate signs of facial aging
- Written informed consent
- Likely to complete all study visits and follow study protocol
Who cannot join
- Any dermatological or medical condition which would make patient participation unsafe or interfere with study outcomes or measurements
- Known hypersensitivity to any study product or their components
- Recent (within 4 weeks of baseline) surgical treatment to face (including IPL and other laser procedures)
- Prior use of anti-aging treatments for 30 days prior to study entry (physician dispensed or prescribed treatments)
- Planned facial procedures during the study (microdermabrasion, facials, etc)
- o Botox and fillers cannot be used during the trial or for 3 months prior to study entry
Show all 11Show fewer
- Recent (within 60 days) or concurrent participation in another clinical trial
- Concomitant topical or systemic therapy that my interfere with study measurements or outcomes
- Use of any other topical photoaging/antiaging therapies during the study, other than the prescribed study regimens
- Patients who are habitual tanners (outdoors or with tanning beds) who plan on tanning during the study
- Wearing of cosmetics during study visits
Trial locations and contacts
1 site in 1 country.
United States1 site
Steve Yoelin MD practice
Santa Ana, California, 92701
About this study
The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging.
- Conditions
- Skin Aging
- Being tested
- Kinerase Pro+Therapy Line day repair, serum, night repair, Kinerase Pro+Therapy Line Ultra rich day repair, LubriDerm
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Kinerase Pro+Therapy Line day repair, serum, night repairDrug
Kinerase Pro+Therapy Line Ultra rich day repairDrug
LubriDermDrug
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Jun 2007 (estimated)
- Study startJun 2007
- Study completionDec 2007
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Skin AgingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
Sponsor and investigators
- Lead sponsor
- Innovative Medical
- Sponsor type
- Industry (pharma, biotech, devices)
- Investigators
- Steven Yoelin, MD, Principal investigator, Private Practice
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00492479
- Sponsor's protocol ID
- 5314
- Status last verified
- Dec 2007
- First submitted
- 25 Jun 2007
- Last updated
- 24 Dec 2007
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Dec 2007. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging
- ClinicalTrials.gov ID
- NCT00492479
- Acronym / sponsor ID
- 5314
- Conditions
- Skin Aging
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Terminated
- Lead sponsor
- Innovative MedicalIndustry (pharma, biotech, devices)
- Study start
- Jun 2007
- Study completion
- Dec 2007 (actual)
- First posted
- 27 Jun 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging.
Study design
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
Who may qualify
- Ages
- 35 to 55 years
- Sex
- Female only
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Female patients 35-55 years of age with at least moderate signs of facial aging
- Written informed consent
- Likely to complete all study visits and follow study protocol
Key exclusion criteria (11 listed)
- Any dermatological or medical condition which would make patient participation unsafe or interfere with study outcomes or measurements
- Known hypersensitivity to any study product or their components
- Recent (within 4 weeks of baseline) surgical treatment to face (including IPL and other laser procedures)
- Prior use of anti-aging treatments for 30 days prior to study entry (physician dispensed or prescribed treatments)
- Planned facial procedures during the study (microdermabrasion, facials, etc)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Kinerase Pro+Therapy Line day repair, serum, night repair | Drug | – |
| Kinerase Pro+Therapy Line Ultra rich day repair | Drug | – |
| LubriDerm | Drug | – |
Primary outcome
Not reported in the source record.
Results and safety
The study was stopped early. Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Dec 2007.
Related trials for Skin Aging
RecruitingObservational study
Improved Facial Skin Quality and Quality of Life After VYC-12L Treatment in Breast Cancer Survivors
Quality of Life, Breast Neoplasms
Active, not recruiting
Integrated Actionable Aging Assessment for Cancer Patients Pilot
Breast Cancer, Hodgkin Lymphoma
Not yet recruitingObservational study
Clinical Research on Deep-Plane Rejuran S Injection for Improvement in the Apperance of Periorbital Hollowing Using a Cannula Technique
Periorbital Hollowing, Skin Aging
Not yet recruitingObservational study
Clinical Evaluation of Dual-Plane Technique PN-Based Treatment for Horizontal Neck Lines Using DNA Fragment Opmizing Technology Polynucleotide (DOT PN)
Skin Aging, Horizontal Neck Lines
Recruiting
Ultraformer MPT Combined With Fractional CO2 Versus Fractional CO2 Alone for Facial Rejuvenation
Skin Aging
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Steven Yoelin, MD principal investigator
Private Practice
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing Kinerase Pro+Therapy Line day repair, serum, night repair, Kinerase Pro+Therapy Line Ultra rich day repair and LubriDerm in people with Skin Aging, run by Innovative Medical at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 24 Dec 2007. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study was stopped early. Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Dec 2007.